Wire · opportunities
New Data at ESC Congress 2026 Validate Caristo's FAI-Score™ Biomarker and Highlight ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
New independent data presented at ESC Congress 2026 validate Caristo's FAI-Score™ as a biomarker for coronary inflammation detectable even in non-contrast cardiac CT scans, showing potential to identify cardiovascular risk beyond traditional factors. Additionally, Caristo's AI platform demonstrated capabilities in predicting stroke risk independent of atrial fibrillation through assessment of left atrial myopathy using routine cardiac CT.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You can now target cardiovascular patients missed by traditional risk tools using AI biomarkers from routine CT scans. Caristo's advances open a new route for earlier screening and intervention without expensive contrast agents.
◆ Coverage
1 source · 31 Aug 2026
◆ Related on Wire
◆ Topics